EKF Diagnostics
1 known investors
EKF Diagnostics develops and manufactures point-of-care in-vitro diagnostic (IVD) medical devices and tests, along with reagents, enzymes, and central-laboratory analysis tools for healthcare providers, clinicians, and researchers. It serves the medical, biotechnology, and pharmaceutical industries, with manufacturing in the USA and Germany and distribution to over 120 countries.
Investors · 1
Acquisitions · 1
Early investors' stakes continue via these deals360 Genomics
Developed a sensitive method for amplifying point mutations in cell-free DNA for early cancer diagnosis; acquired by EKF Diagnostics in 2013.
Frequently asked questions
- What does EKF Diagnostics do?
- EKF Diagnostics develops and manufactures point-of-care in-vitro diagnostic (IVD) medical devices and tests, along with reagents, enzymes, and central-laboratory analysis tools for healthcare providers, clinicians, and researchers. It serves the medical, biotechnology, and pharmaceutical industries, with manufacturing in the USA and Germany and distribution to over 120 countries.
- Who are EKF Diagnostics's investors?
- EKF Diagnostics's investors include H20 Venture Partners.